Tachycardia induced Cardiomyopathy.
Kim DY, Kim SH, Ryu KH.
Korean Circ J. 2019 Sep;49(9):808-817. doi: 10.4070/kcj.2019.0199.
Tachycardia-Induced Cardiomyopathy: A Fascinating Clinical Entity.
Katritsis DG.
JACC Case Rep. 2021 Mar 17;3(3):484-485. doi: 10.1016/j.jaccas.2021.01.020. eCollection 2021 Mar.
Tachycardia-induced cardiomyopathy.
Umana E, Solares CA, Alpert MA.
Am J Med. 2003 Jan;114(1):51-5. doi: 10.1016/s0002-9343(02)01472-9.
Tachycardia-induced cardiomyopathy.
Ahmadi A, Zolfi-Gol A, Arasteh M.
ARYA Atheroscler. 2014 May;10(3):175-8.
Emerging concepts in heart failure management and treatment: focus on tachycardia-induced cardiomyopathy.
Báez Cabanillas MV, Colque R, Tibaldi MÁ, Kaplinsky E, Perrone S, Barbagelata A.
Drugs Context. 2023 Jan 4;12:2022-8-4. doi: 10.7573/dic.2022-8-4. eCollection 2023.
[Tachycardia-induced cardiomyopathy].
Povolný J.
Vnitr Lek. 2015 Jan;61(1):56-9.
Tachycardia-Induced Cardiomyopathy in an Infant with Atrial Flutter and Prolonged Recovery of Cardiac Function.
Sakai T, Tsuboi K, Takarada S, Okabe M, Nakaoka H, Ibuki K, Ozawa SW, Hata Y, Ichimata S, Nishida N, Hirono K.
J Clin Med. 2024 Jun 4;13(11):3313. doi: 10.3390/jcm13113313.
Tachycardia-induced cardiomyopathy.
Nakatani BT, Minicucci MF, Okoshi K, Politi Okoshi M.
BMJ Case Rep. 2012 Sep 21;2012:bcr2012006587. doi: 10.1136/bcr-2012-006587.
Tachycardia-Induced Cardiomyopathy in a Young Healthy Patient: A Case Report.
Khan Z, Besis G, Tomson J.
Cureus. 2022 Sep 8;14(9):e28932. doi: 10.7759/cureus.28932. eCollection 2022 Sep.
Tachycardia-induced metabolic rewiring as a driver of contractile dysfunction.
Tu C, Caudal A, Liu Y, Gorgodze N, Zhang H, Lam CK, Dai Y, Zhang A, Wnorowski A, Wu MA, Yang H, Abilez OJ, Lyu X, Narayan SM, Mestroni L, Taylor MRG, Recchia FA, Wu JC.
Nat Biomed Eng. 2024 Apr;8(4):479-494. doi: 10.1038/s41551-023-01134-x. Epub 2023 Nov 27.
